The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 50.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 4.00 (8.00%)
Open: 52.00
High: 0.00
Low: 0.00
Prev. Close: 52.00
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Nov 2023 16:30

RNS Number : 8352S
Frenkel Topping Group PLC
08 November 2023

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group")

Director/PDMR Dealing

Frenkel Topping (AIM: FEN), a specialist financial and professional services firm operating within the personal injury and clinical negligence marketplace, announces that on 8 November 2023 it was informed that Richard Fraser, Chief Executive Officer, has purchased 26,000 ordinary shares of 0.5p each in the capital of the Company ("Ordinary Shares"), from his wife, Norma Fraser's SIPP for estate and tax planning purposes , at a price of 53.5p pence per Ordinary Share.

Following the transaction in the Company's ordinary shares Mr. Fraser's (and persons closely associated ("PCAs") to him) beneficial holding in the Company will remain unchanged at 1,895,907 Ordinary Shares of the Company, representing approximately 1.68 per cent. of the Company's issued share capital.

For further information:

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

finnCap Ltd (Nominated Advisor & Broker)

Tel: 020 7220 0500

Carl Holmes/Abigail Kelly (Corporate Finance)

Tim Redfern / Charlotte Sutcliffe (ECM)

About Frenkel Topping Group:

The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).

For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.

Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.

The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.

The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).

Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

For more information visit: www.frenkeltoppinggroup.co.uk

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fraser

2.

Reason for the Notification

a)

Position/status

Richard Fraser, Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frenkel Topping Group plc

b)

LEI

213800I5L3K7AT7A4R20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares

Identification code

GB00B01YXQ71

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)

Prices (pence)

26,000

53.5p

d)

Aggregated information:

· Aggregated volume

· Price

e)

Date of the transaction

8 November 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Norma Fraser

2.

Reason for the Notification

a)

Position/status

PCA of Richard Fraser, Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frenkel Topping Group plc

b)

LEI

213800I5L3K7AT7A4R20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

New Ordinary Shares

Identification code

GB00B01YXQ71

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Volume(s)

Prices (pence)

26,000

53.5p

d)

Aggregated information:

· Aggregated volume

· Price

e)

Date of the transaction

8 November 2023

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQVLFBXFLLFBD
Date   Source Headline
9th Sep 200811:45 amRNSDirector/PDMR Shareholding
21st Aug 200811:27 amRNSInterim Results
13th Jun 20083:22 pmRNSHolding(s) in Company
14th May 200810:11 amRNSDirectorate Change
24th Apr 20082:44 pmRNSDirector/PDMR Shareholding
27th Mar 20083:52 pmRNSDirector/PDMR Shareholding
27th Mar 200812:26 pmRNSFinal Results
2nd Jan 200810:32 amRNSChange of Registered Office
19th Dec 20073:56 pmRNSDirector/PDMR Shareholding
28th Nov 200712:33 pmRNSDirector/PDMR Shareholding
14th Nov 200711:07 amRNSHolding(s) in Company
9th Nov 20073:58 pmRNSDirector/PDMR Shareholding
9th Oct 20072:51 pmRNSHolding(s) in Company
9th Oct 20072:46 pmRNSDirector/PDMR Shareholding
21st Aug 20072:30 pmRNSDirector/PDMR Shareholding
16th Aug 20072:09 pmRNSAIM Rule 26 Information
13th Aug 20079:58 amRNSInterim Results
10th Jul 20072:20 pmRNSDirectorate Change
10th May 200710:44 amRNSLoan Agmnt & Issue of Options
26th Mar 200711:42 amRNSFinal Results
19th Dec 20063:39 pmRNSTotal Voting Rights
8th Dec 20064:44 pmRNSDirector/PDMR Shareholding
1st Dec 200612:48 pmRNSHolding(s) in Company
24th Nov 200611:52 amRNSHolding(s) in Company
19th Sep 20061:26 pmRNSHolding(s) in Company
31st Aug 20064:38 pmRNSDirector/PDMR Shareholding
22nd Aug 20062:51 pmRNSIssue of Equity
26th Jul 20062:30 pmRNSInterim Results
19th Jul 200612:27 pmRNSIssue of Equity
9th Jun 20069:12 amRNSHolding(s) in Company
11th May 20064:03 pmRNSHolding(s) in Company
27th Apr 20063:01 pmRNSDirectorate Change
31st Mar 20064:22 pmRNSFinal Results
27th Sep 20057:00 amRNSInterim Results
27th Jul 20054:20 pmRNSDisposal
21st Apr 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.